Viswanath, B., Rajesh, B., Janardhan, A., Kumar, A
In December 2024, the FDA approved a Victoza generic, simply known as liraglutide, made by Teva Pharmaceuticals and Hikma Pharmaceuticals
Those pounds, like most of the others lost on semaglutide, dropped because she was less hungry than before
Both are GLP-1-class weight loss / diabetes drugs, but tirzepatide adds GIP receptor activity that semaglutide doesn't have, which is why tirzepatide produces larger weight loss in head-to-head trials
Additionally, factors like diet, exercise, and overall adherence to the treatment plan can influence outcomes
Abstract Metabolic syndrome is characterized by central obesity, insulin resistance, elevated blood pressure, and dyslipidemia